期刊文献+

GRADE指南:Ⅵ.证据质量评价--不精确性(随机误差) 被引量:46

GRADE guidelines: 6. Rating the quality of evidence——imprecision
原文传递
导出
摘要 GRADE建议通过检查95%可信区间(CI)为决定不精确性的最佳方法。在指南实际运用中,如果CI的上、下限值代表了真实效应,而临床实际情况与之不符时,必须降低证据质量级别(即对效应估计值的把握度)。除外当效应值很大且可信区间提示效应稳健,而总样本量不大且事件数很少的情况,其他应考虑因不精确性而降低证据质量级别。作此决定时,可计算有足够检验效能的单个试验所需的病例数(定义为"最优信息样本量",即optimal information size,OIS)。对连续型变量,我们建议用类似方法,首先考虑可信区间上、下限值,再计算OIS。系统评价(SR)所需方法略有不同。如果95%CI不包括相对危险度(RR)为1,且总事件发生数或病例数超过OIS标准,则精确性良好。如果95%CI包括了明显获益或危害(我们建议以RR值<0.75或>1.25作粗标准),即使达到OIS要求,因不精确性而降低证据质量级别较恰当。
出处 《中国循证医学杂志》 CSCD 2011年第12期1435-1443,共9页 Chinese Journal of Evidence-based Medicine
  • 相关文献

参考文献25

  • 1A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348: 1329-1339.
  • 2Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med, 1999, 341: 1789-1794.
  • 3Pocock SJ, Hughes MD. Practical problems in interim analyses, with particular regard to estimation. Control Clin Trials, 1989, 10: 209S- 21S.
  • 4Montori VM, Devereaux PJ, Adhikari NK, et al. Randomized tri- als stopped early for benefit: a systematic review. JAMA, 2005, 294: 2203-2209.
  • 5Bassler D, Briel M, Montori VM, et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic re- view and meta-regression anarysis, JAMA, 2010, 303: 1180-1187.
  • 6Teo KK, Yusuf S, Collins R, et al. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ, 1991, 303:1499-1503.
  • 7ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet, 1995, 345: 669-685.
  • 8Abuissa H, Jones PG, Marso SP, et al. Angiotensin-converting en- zyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Call Cardiol, 2005, 46:821-826.
  • 9Bosch J, Yusuf S, Gerstein HC, et al. Effect of ramipril on the inci- dence of diabetes. N Engl J Med, 2006, 355:1551-1562.
  • 10Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ, 2005, 331: 313-321.

同被引文献670

引证文献46

二级引证文献218

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部